SCHEMBL29925189

SCHEMBL29925189

CCN(CC)CCCN1C(c2ccc(CN(C)C)cc2)=CN2c3ccccc3SC12

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ SIGMAR1 Q99720 2/20 0.34
▸ CHRM2 P08172 2/20 0.33
▸ CHRM4 P08173 2/20 0.33
▸ HTR1A P08908 2/20 0.33
▸ CHRM5 P08912 2/20 0.33
▸ CHRM1 P11229 2/20 0.33
▸ ADRA2C P18825 2/20 0.33
▸ CHRM3 P20309 2/20 0.33
▸ HRH2 P25021 2/20 0.33
▸ HTR2A P28223 2/20 0.33
▸ HTR2C P28335 2/20 0.33
▸ HRH1 P35367 2/20 0.33
▸ DRD3 P35462 2/20 0.33
▸ HTR2B P41595 2/20 0.33
▸ KDM1A O60341 2/20 0.33
▸ CYP1A2 P05177 2/20 0.33
▸ CYP2D6 P10635 2/20 0.33
▸ CYP2C19 P33261 2/20 0.33
▸ HIF1A Q16665 2/20 0.33
▸ SLC22A1 O15245 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30085747 0.91 POLB (0.34) SIGMAR1CHRM2CHRM4HTR1ACHRM5
SCHEMBL29925418 0.89 POLB (0.35) CHRM2CHRM4HTR1ACHRM5CHRM1
SCHEMBL29924890 0.87 BCHE (0.32) CHRM2CHRM4HTR1ACHRM5CHRM1
SCHEMBL30085741 0.87 CACNA1C (0.41) SIGMAR1CHRM2CHRM4HTR1ACHRM5
SCHEMBL29924955 0.86 MEN1 (0.37) CHRM2CHRM4HTR1ACHRM5CHRM1
SCHEMBL30085704 0.85 SMPD1 (0.37) CHRM2CHRM4HTR1ACHRM5CHRM1
SCHEMBL30085762 0.85 BCHE (0.33) SIGMAR1CHRM2CHRM4HTR1ACHRM5
SCHEMBL29924716 0.85 HRH3 (0.42) CHRM1HTR2ACYP2D6CYP2C19ALDH1A1
SCHEMBL30085736 0.85 MAPK13 (0.36) SIGMAR1CHRM2CHRM4HTR1ACHRM5
SCHEMBL30085743 0.84 KDM4E (0.37) CHRM2CHRM4HTR1ACHRM5CHRM1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4274569-A1 C-MYC MRNA TRANSLATION MODULATORS AND USES THEREOF IN THE TREATMENT OF CANCER Anima Biotech Inc. (US) 2023-11-15 — — EP disclosed
WO-2022150316-A1 C-MYC MRNA TRANSLATION MODULATORS AND USES THEREOF IN THE TREATMENT OF CANCER ANIMA BIOTECH INC. (US) 2022-07-14 — — WO disclosed
Send feedback